MTRI · InMed Pharmaceuticals Inc. · Suppliers & Customers
$18.79
+0.44 (+2.37%)
At close · Nov 13
Return incl. dividend (before tax)
Q4 2021 earnings call transcript
Going-concern doubt
— flagged Nov 3, 2026
Substantial doubt about the company's ability to continue as a going concern.
“We have concluded that there is substantial doubt about our ability to continue as a going concern within one year after the date that the condensed consolidated financial statements are issued.”View the 10-Q filed Nov 3, 2026
Market Cap
$8.58M
Shares
549,374
Volume · Nov 13
7698
Avg daily vol (6 sessions)
62.9K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Supply Chain
Customers, suppliers, competitors and partners, private companies included: the ones MTRI names, and the companies that name MTRI.
Read supply chains in your AI or your code through MCP and the API →
Pro
See who MTRI sells to, buys from, competes and partners with
- 0 suppliers
- 0 customers
- 1 competitor
- 1 partner
Pro names each company, links it to its own page, shows any revenue share the filing states, and quotes the sentence it comes from.